Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Toyama to begin U.S. development of Alzheimer's drug

Oct. 20, 1997

Warner-Lambert prepares new cyclic amino acids related to gabapentin

Oct. 20, 1997

U-101033E vs. U-74389G in rat model of focal cerebral ischemia

Oct. 17, 1997

AMPA receptor antagonists prepared at Schering AG

Oct. 17, 1997

New dopamine beta-hydroxylase inhibitors derived from lettuce

Oct. 17, 1997

SKB claims 5-HT7 receptor antagonists

Oct. 17, 1997

Potent alpha2-adrenoceptor blockers prepared by Pierre Fabre

Oct. 16, 1997

Dose-dependent pain relief with Quadramet in breast and prostate cancer patients

Oct. 16, 1997

SmithKline Beecham launches ReQuip in the U.S.

Oct. 15, 1997

Feasibility of OROS melatonin delivery evaluated in humans

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...